Study reveals immune system's crucial role in amyotrophic lateral sclerosis at cellular level
A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...
How this Veteran turned grief into purpose
ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...
Fierce Biotech2d
Journey of Voyager's ALS gene therapy to clinic hindered by need to find alternative payload
The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...
Fierce Pharma1d
Biogen CEO hails quartet of new launches as multiple sclerosis competition weighs on 2025 guidance
While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...
Wake County deputy’s career cut short by ALS. Will the county help him and his family?
Roy and his wife, Jamie, asked Wake County to offer that lump sum to officers like him who medically retire but don’t ...
Voyager to assess alternate payloads for SOD1 ALS gene therapy program
Voyager Therapeutics (VYGR) has decided to assess alternate payloads related to its gene therapy program for superoxide dismutase 1 amyotrophic ...
Voyager Provides Update on SOD1 ALS Gene Therapy Program
Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs extends cash ...
Mena FN10d
Amyotrophic Lateral Sclerosis Treatment Market To Surpass USD 1021 Million By 2032
The Global Amyotrophic Lateral Sclerosis Treatment Market was valued at USD 634 Million in 2023 and expected to grow USD 1021 Million in 2032. Sporadic ALS Holds The Largest Market Share In The Type ...